Lower mortality in patients with the DD genotype of the angiotensin-converting enzyme gene after acute myocardial infarction

Acta Cardiologica

Volumn 56, Issue 6, 2001, Pages 351-355

  Tokunaga, Satoshi ^a   Tsuji, Hisako ^a   Nishiue, Takashi ^a   Yamada, Koichi ^a   Miyasaka, Yoko ^a   Saitou, Daiki ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin; Mortality; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEART DEATH; HEART MUSCLE REPERFUSION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY;

EID: 0035746556     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.56.6.2005698     Document Type: Article

References (39)

1. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
2. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis
3. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients
4. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy
5. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy
6. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients
7. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension
8. A potent genetic risk factor for restenosis
9. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting
10. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy
11. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
12. Angiotensin-converting enzyme in the human heart: Effect of the deletion/insertion polymorphism
13. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure
14. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease
15. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease
16. ACE gene polymorphism: Ischemic heart disease and longevity in 10, 150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study
17. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls
18. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass
19. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty
20. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty
21. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement
22. Genetic associations with human longevity at the APOE and ACE loci
23. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction
24. Mistyping ACE heterozygotes
25. Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilatation after anterior myocardial infarction
26. The genotype of the angiotensin-converting enzyme gene and global left ventricular dysfunction after myocardial infarction
27. Is pre-CCU thrombolytic necessary?
28. The D allele of the angiotensin-converting enzyme gene and reperfusion-induced ventricular arrhythmias in patients with acute myocardial infarction
29. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts
30. Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts
31. Clinical predictors of heart failure in patients with first acute myocardial infarction
32. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: Observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study
33. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese
34. Significance of the deletion polymorphism of the angiotensin-converting enzyme gene as a risk factor for myocardial infarction in Japanese
35. Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension: Multicenter study of 1,919 subjects
36. DD genotype of the angiotensin I-converting enzyme gene is a risk factor for early onset of essential hypertension in Japanese patients
37. Angiotensin-converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients
38. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene affects heart weight